52 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Lilly's Stock Up on Upbeat Sales & Profit Outlook for 2020 http://www.zacks.com/stock/news/676513/lillys-stock-up-on-upbeat-sales-profit-outlook-for-2020?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-676513 Dec 18, 2019 - Eli Lilly's (LLY) stock up on Tuesday after it provides an upbeat financial guidance for the next year.
Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial http://www.zacks.com/research-daily/676738/top-stock-reports-for-johnson-johnson-eli-lilly-pnc-financial?cid=CS-ZC-FT-research_daily-676738 Dec 18, 2019 - Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial
The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland http://www.zacks.com/stock/news/678361/the-zacks-analyst-blog-highlights-johnson-johnson-eli-lilly-pnc-financial-eog-resources-and-archer-daniels-midland?cid=CS-ZC-FT-press_releases-678361 Dec 19, 2019 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland
Gilead (GILD) Files NDA With FDA for RA Candidate Filgotinib http://www.zacks.com/stock/news/679808/gilead-gild-files-nda-with-fda-for-ra-candidate-filgotinib?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-679808 Dec 20, 2019 - Gilead (GILD) files an NDA for filgotinib with the FDA for the treatment of adults with moderate-to-severe rheumatoid arthritis.
Pharma Stock Roundup: Lilly's Upbeat 2020 Outlook, FDA Nod for PFE & MRK's Drugs http://www.zacks.com/stock/news/679924/pharma-stock-roundup-lillys-upbeat-2020-outlook-fda-nod-for-pfe-mrks-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-679924 Dec 20, 2019 - Lilly (LLY) issues upbeat financial guidance for 2020. FDA approves label expansion of Pfizer's (PFE) Xtandi and Merck's (MRK) Ebola vaccine, Ervebo.
Top Stock Reports for SAP, AbbVie & Sinopec http://www.zacks.com/research-daily/684233/top-stock-reports-for-sap-abbvie-sinopec?cid=CS-ZC-FT-research_daily-684233 Dec 23, 2019 - Top Stock Reports for SAP, AbbVie & Sinopec
4 GARP Stocks to Scoop Up for Maximum Returns http://www.zacks.com/stock/news/704702/4-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-704702 Jan 06, 2020 - If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020 http://www.zacks.com/stock/news/707821/3-pharma-biotech-pipeline-areas-to-keep-an-eye-on-in-2020?cid=CS-ZC-FT-analyst_blog|industry_focus-707821 Jan 08, 2020 - Here we present three non-cancer therapeutic areas wherein pipeline developments are expected to garner a lot of interest in 2020.
Benzinga Pro's Top 5 Stocks To Watch For Fri., Jan. 10, 2020: LLY, JPM, SRNE, ELAN, TWTR http://feeds.benzinga.com/~r/benzinga/~3/3IIihItXQgA/benzinga-pros-top-5-stocks-to-watch-for-fri-jan-10-2020-lly-jpm-srne-elan-twtr Jan 10, 2020 -

Benzinga Pro's Stocks To Watch For Friday

Eli Lilly (LLY) - Shares were quiet Friday morning despite news the company will purchase Dermira (DERM) for $18.75/share in cash. Dermira shares were up

read more

All the 2020 Pre-JPM News Healthcare Investors Need to Know https://www.fool.com/investing/2020/01/11/all-the-2020-pre-jpm-news-healthcare-investors-nee.aspx?source=iedfolrf0000001 Jan 11, 2020 - The Super Bowl of healthcare kicked off early for these companies.

Pages: 123456

<<<Page 4>